China Approves Its Homegrown COVID-19 Vaccine For Widespread Use
The state-owned Sinopharm says its vaccine has a 79% efficacy rate — surpassing the widely accepted standard of 50% efficacy.
Read more on NPR
Thursday, 31 December 2020
China Approves Its Homegrown COVID-19 Vaccine For Widespread Use
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment
Nothing happens without a Reason
Make Something out of it.